What is the management of each sickle cell crisis: vaso‑occlusive pain crisis, acute chest syndrome, splenic sequestration, transient aplastic crisis, acute stroke, and priapism?

Management of Sickle Cell Crises

Vaso-Occlusive Pain Crisis

Rapid administration of parenteral opioids is the cornerstone of treatment, with scheduled around-the-clock dosing or patient-controlled analgesia (PCA) for severe pain. 1

Immediate Assessment and Triage

• Trust the patient's self-report of pain—diagnosis is entirely clinical without requiring specific laboratory abnormalities 1
• Rapidly triage patients reporting acute pain consistent with their typical crisis pattern 1
• Exclude life-threatening complications including acute chest syndrome, stroke, and splenic sequestration 2, 1

Pain Management Protocol

• Administer aggressive parenteral analgesia with opioids promptly 1
• Use scheduled around-the-clock dosing or PCA for severe pain rather than as-needed dosing 1
• Continue opioid therapy until pain resolves, typically requiring several days of hospitalization 3

Supportive Care Measures

• Maintain adequate hydration with intravenous fluids 4, 3
• Target oxygen saturation of 94-98% or the patient's usual baseline saturation 4
• Only administer supplemental oxygen if hypoxemia is documented—avoid empiric oxygen in normoxic patients 4, 3
• Implement incentive spirometry to prevent acute chest syndrome 3
• Maintain normothermia and acid-base balance 4

Critical Pitfall

• Do not delay analgesia waiting for laboratory results in patients with known sickle cell disease presenting with typical pain 2

---

Acute Chest Syndrome

Exchange transfusion or simple transfusion to reduce hemoglobin S below 30% is the definitive treatment, combined with broad-spectrum antibiotics, supplemental oxygen, and aggressive pain control. 4, 3, 5

Diagnostic Criteria

• New pulmonary infiltrate on chest radiograph plus respiratory symptoms (chest pain, cough, dyspnea, hypoxia) 2, 1
• This is the most common cause of ICU admission and death in adults with sickle cell disease 6

Immediate Management

• Administer broad-spectrum antibiotics covering atypical organisms 3, 5
• Provide supplemental oxygen to maintain saturation 94-98% 4, 3
• Initiate aggressive pain control with opioids 3
• Implement incentive spirometry every 2 hours while awake 3

Transfusion Therapy

• Simple transfusion is effective in more than 75% of cases and should be the initial approach 5
• Exchange transfusion is indicated for severe cases, multi-lobar involvement, or rapid deterioration 3, 5
• Target hemoglobin S level below 30% of total hemoglobin 4, 7

Respiratory Support

• Consider non-invasive ventilation (CPAP or BiPAP) for respiratory distress 3
• Intubation and mechanical ventilation may be required for respiratory failure 3, 6

Adjunctive Therapies

• Systemic corticosteroids may be considered in severe cases, though evidence is limited 3
• Maintain adequate hydration without fluid overload 3

Critical Pitfall

• Acute chest syndrome can develop during hospitalization for vaso-occlusive crisis—monitor closely for chest pain, fever, or respiratory symptoms 2, 3

---

Splenic Sequestration

Immediate aggressive fluid resuscitation followed by urgent simple transfusion to restore circulating blood volume is life-saving, with splenectomy considered for recurrent episodes. 6, 7

Recognition and Diagnosis

• Rapidly enlarging spleen with hemoglobin decrease >2 g/dL below baseline 4, 2
• Can progress rapidly to hypovolemic shock and death 6, 7
• Most common in children under 5 years of age 6

Emergency Management

• Aggressive intravenous fluid resuscitation to maintain adequate circulation 6, 7
• Urgent simple transfusion of packed red blood cells to restore hemoglobin and circulating volume 5, 7
• Monitor for rebound hyperviscosity as sequestered red cells re-enter circulation after transfusion 7

Definitive Treatment

• Splenectomy should be considered after recovery from acute episode to prevent recurrence 4, 7
• Ensure pneumococcal and meningococcal vaccination before splenectomy 4
• Lifelong penicillin prophylaxis after splenectomy 4

Critical Pitfall

• Splenic sequestration can rapidly progress to shock—do not delay transfusion for diagnostic workup 6, 7

---

Transient Aplastic Crisis

Simple transfusion of packed red blood cells is the primary treatment, with supportive care until bone marrow recovery occurs. 7

Recognition and Diagnosis

• Acute worsening of baseline anemia with decreased or absent reticulocyte count 1, 7
• Usually triggered by parvovirus B19 infection 7
• Distinguished from other crises by reticulocytopenia rather than reticulocytosis 1

Management

• Transfuse packed red blood cells to maintain adequate oxygen-carrying capacity 7
• Provide supportive care including hydration and monitoring 7
• Bone marrow recovery typically occurs within 7-10 days 7
• Isolation precautions to prevent parvovirus transmission to other susceptible patients 7

Critical Pitfall

• Do not confuse with splenic sequestration—aplastic crisis has low reticulocyte count, while sequestration has elevated reticulocyte count 1, 7

---

Acute Stroke

Immediate exchange transfusion to reduce hemoglobin S below 30% is the emergency treatment, followed by chronic transfusion therapy for secondary stroke prevention. 4, 7

Emergency Recognition

• Any acute neurologic symptom beyond transient mild headache requires urgent neuroimaging 2
• Symptoms include hemiparesis, aphasia, seizures, severe headache, cranial nerve palsy, stupor, or coma 2
• Stroke affects up to 10% of children with sickle cell disease 2

Immediate Management

• Urgent CT or MRI to confirm ischemic versus hemorrhagic stroke 4, 2
• Emergency exchange transfusion to reduce hemoglobin S to <30% of total hemoglobin 4, 7
• Maintain hydration, normoglycemia, and avoid hypoxemia or hypotension 4
• Target oxygen saturation 94-98% or 88-92% if at risk of hypercapnic respiratory failure 4

Hemorrhagic Stroke Management

• Defer cerebral angiography until after exchange transfusion reduces hemoglobin S percentage 4
• Evaluate for aneurysm, especially in adolescents and adults with subarachnoid hemorrhage 4

Secondary Prevention

• Chronic transfusion therapy every 3-4 weeks to maintain hemoglobin S <30% 4, 7
• Continue transfusions for at least 5 years or until age 18 years 4
• Annual stroke recurrence rate is approximately 2% despite ongoing transfusion 4
• Manage iron overload from chronic transfusions with chelation therapy 4

Critical Pitfall

• Do not delay exchange transfusion for diagnostic workup—stroke-free survival is 80% at 50 months with chronic transfusion versus 30% without treatment 4

---

Priapism

Intracavernosal phenylephrine (100-500 µg/mL, maximum 1,000 µg in first hour) combined with corporal aspiration and irrigation is first-line treatment for ischemic priapism lasting >4 hours. 8

Emergency Recognition

• Any erection lasting >4 hours is a urological emergency requiring immediate intervention 8
• Ischemic priapism presents with rigid, painful corpora cavernosa with soft glans 8
• Permanent erectile dysfunction risk increases dramatically after 24 hours and is highly likely after 36 hours 8

Immediate Diagnostic Evaluation

• Perform corporal blood gas analysis to confirm ischemic priapism: PO₂ <30 mmHg, PCO₂ >60 mmHg, pH <7.25 8
• Assess duration of erection, baseline erectile function, and any precipitating medications 8

Treatment Algorithm by Duration

<4 Hours (Post-Intracavernosal Injection)

• Immediate intracavernosal phenylephrine if erection is fully rigid 8
• Brief observation if only partially rigid 8

4-24 Hours

• Intracavernosal phenylephrine (100-500 µg/mL) plus corporal aspiration and saline irrigation 8
• Success rate 43-81% for detumescence and preservation of erectile function 8
• Maximum 1,000 µg phenylephrine in first hour 8

24-36 Hours

• Continue phenylephrine with aspiration/irrigation 8
• Proceed to distal surgical shunting if refractory to medical therapy 8
• Risk of permanent erectile dysfunction rises markedly 8

>36 Hours

• Distal surgical shunting (Winter or Al-Ghorab procedure) usually required 8
• Permanent erectile dysfunction highly probable with minimal chance of recovery 8
• Early discussion of penile prosthesis implantation as definitive treatment 8

Sickle Cell-Specific Considerations

• Do not postpone urologic intervention for exchange transfusion—this adds >6 hours without proven benefit 8
• Administer standard ischemic priapism protocol immediately 8
• Provide concurrent systemic sickle cell management (hydration, analgesia) 8
• Simple transfusion to raise hemoglobin to 9-10 g/dL may be considered before general anesthesia if surgery anticipated 8

Critical Pitfalls

• Do not delay treatment beyond 4 hours—smooth muscle edema and atrophy begin as early as 6 hours 8
• Phenylephrine is the only recommended sympathomimetic; epinephrine and norepinephrine are contraindicated 8
• Aspiration or sympathomimetic alone is less effective than combination therapy 8